PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

ASU researchers develop new device to help image key proteins at room temperature

2013-12-20
(Press-News.org) Contact information: Skip Derra
skip.derra@asu.edu
480-965-4823
Arizona State University
ASU researchers develop new device to help image key proteins at room temperature TEMPE, Ariz. – A group of researchers from Arizona State University are part of a larger team reporting a major advance in the study of human proteins that could open up new avenues for more effective drugs of the future. The work is being reported in this week's Science magazine.

In the paper, "Serial femtosecond crystallography of G-protein-coupled receptors," the team reports that they have been successful in imaging at room temperature the structure of G protein-coupled receptors (GPCR) with the use of an x-ray free-electron laser.

GPCR's are a highly diverse group of membrane proteins that mediate cellular communication. Because of their involvement in key physiological and sensory processes in humans, they are thought to be prominent drug targets.

The method described in the paper was applied for the first time to this important class of proteins, for which the 2012 Nobel Prize was awarded to Brian Kobilka and Robert Lefkowitz, said John Spence, an Arizona State University professor of physics. Spence also is the director of science at National Science Foundation's BioXFEL Science and Technology Center and a team member on the Science paper.

"These GPCR's are the targets of a majority of drug molecules," Spence said, but they are notoriously difficult to work with. This is the first time structural observations of the GPCR's have been made at room temperature, allowing researchers to overcome several disadvantages of previous imaging methods of the proteins.

"Normally, protein crystallography is performed on frozen samples, to reduce the effects of radiation damage," Spence said. "But this new work was based on an entirely new approach to protein crystallography, called SFX (Serial Femtosecond Crystallography) developed jointly by ASU, the Deutsches Elektronen-Synchrotron (DESY) and the SLAC National Accelerator Laboratory."

"This method uses brief pulses of x-rays instead of freezing the sample to avoid damage, and so it reveals the structure which actually occurs in a cell at room temperature, not the frozen structure," Spence added. "The 50 femtosecond pulses (120 per second) 'outrun' radiation damage, giving a clear picture of the structure before it is vaporized by the beam."

The femtosecond crystallography technique could enable researchers to view molecular dynamics at a time-scale never observed before. Spence said the method basically operates by collecting the scattering for the image so quickly that images are obtained before the sample is destroyed by the x-ray beam.

By 'outrunning' radiation-damage processes in this way, the researchers can record the time-evolution of molecular processes at room temperature, he said.

Spence said ASU played a crucial role in the project described in Science, through the invention by Uwe Weierstall (an ASU physics professor) of an entirely new device for sample delivery suited to this class of proteins.

The lipic cubic phase (LCP) injector that Weierstall developed replaces the continuous stream of liquid (which sends a continuously refreshed stream of proteins across the pulsed x-ray beam) with a slowly moving viscous stream of 'lipid cubic phase solution,' which has the consistency of automobile grease.

"We call it our 'toothpaste jet,'" Spence said.

He added that the LCP solves three problems associated with previous SFX work, and made this new work possible: The viscosity slows the flow rate so the crystals emerge at about the same rate as the x-ray pulses come along, hence no protein is wasted. This is important for the study of human protein, which is more costly than diamond on a per gram basis. The "hit rate" is very high. Nearly all x-ray pulses hit protein particles. Most important, LCP is itself a growth medium for protein nanocrystals.

"A big problem with the SFX work we have been doing over the past four years is that people did not know how to make the required nanocrystals," Spence said. "Now it seems many can be grown in the LCP delivery medium itself."

### The international team reporting the advance in Science includes researchers from the Scripps Research Institute, La Jolla, Calif., the Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany; the Department of Physics and the Department of Chemistry and Biochemistry at ASU, Tempe, Ariz.; SLAC National Accelerator Laboratory, Menlo Park, Calif.; Trinity College, Dublin, Ireland; Uppsala University, Sweden; University of Hamburg, Germany; and Center for Ultrafast Imaging, Hamburg, Germany.

Petra Fromme led the ASU group that helped plan the experiments, characterize the samples and assist with data collection. Other members of the ASU team include: Daniel James, Dingjie Wang, Garrett Nelson, Uwe Weierstall, Nadia Zatsepin, Richard Kirian, Raimund Fromme, Shibom Basu, Christopher Kupitz, Kimberley Rendek, Ingo Grotjohann, and John Spence.

Source: John Spence, (480) 965-6486

Media contact: Skip Derra, (480) 965-4823; skip.derra@asu.edu


ELSE PRESS RELEASES FROM THIS DATE:

91 new species described by California Academy Of Sciences in 2013

2013-12-20
91 new species described by California Academy Of Sciences in 2013 SAN FRANCISCO (December 20, 2013) — In 2013, researchers at the California Academy of Sciences discovered 91 new plant and animal species and two new genera, enriching our understanding ...

JCI early table of contents for Dec. 20, 2013

2013-12-20
JCI early table of contents for Dec. 20, 2013 Fungal surface protein promotes host cell Opportunistic infection of individuals on immunosuppressive therapy are a major problem for patient outcome, despite current prophylactic strategies. While the ability ...

Fungal surface protein promotes host cell

2013-12-20
Fungal surface protein promotes host cell Opportunistic infection of individuals on immunosuppressive therapy are a major problem for patient outcome, despite current prophylactic strategies. While the ability to prevent infection with well-characterized ...

Angiogenic factor secretion by melanocytes associated with pigmentation leve

2013-12-20
Angiogenic factor secretion by melanocytes associated with pigmentation leve The decreased vision loss that accompanies age-related macular degeneration (AMD) is associated with abnormal blood vessel growth in the eye. Frequencies of AMD development are ...

Nonsense suppression drug restores function in a mouse model of aniridia

2013-12-20
Nonsense suppression drug restores function in a mouse model of aniridia Congenital aniridia is a progressive disease that is associated with improper development of eye structures as well as abnormalities in the brain and pancreas. A variety of nonsense ...

Dysfunctional TGF-beta signaling contributes to Loeys-Dietz syndrome-associated aortic aneurysm

2013-12-20
Dysfunctional TGF-beta signaling contributes to Loeys-Dietz syndrome-associated aortic aneurysm Patients with the connective tissue disorder Loeys-Dietz syndrome (LDS) are at high risk for aortic aneurysm. LDS results in the presence of missense mutations ...

Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy

2013-12-20
Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, ...

New research offers hope for vaccine and therapies for deadly infections

2013-12-20
New research offers hope for vaccine and therapies for deadly infections LA BioMed researcher leads team that finds antibodies to protect against mucormycosis LOS ANGELES – (Dec. 20, 2013) – Mucormycosis ...

UBC-VCH scientists use drug to repair rare birth defect

2013-12-20
UBC-VCH scientists use drug to repair rare birth defect Success in mouse model is first instance of drug reversing a congenital deformity University of British Columbia and Vancouver Coastal Health scientists have developed a potential cure for a rare eye disease, ...

Enlisting cells' protein recycling machinery to regulate plant products

2013-12-20
Enlisting cells' protein recycling machinery to regulate plant products New molecular tools for controlling production of compounds important for flavors, human health, and biofuels UPTON, NY--Scientists at the U.S. Department of Energy's Brookhaven ...

LAST 30 PRESS RELEASES:

Women who work nightshifts are more likely to have asthma

Video consultations are faster, cheaper and more sustainable for patients

Neuroscience drives new wellbeing app

MOVEO project kicks off in Málaga to shape the future of smarter, smoother mobility across Europe

Are the rest of podcasters history? AI-generated podcasts open new doors to make science accessible

Two frontiers: Illinois experts combine forces to develop novel nanopore sensing platform

Biotechnology governance entreaties released, echoing legacy of 1975 recombinant DNA guidelines

Review of active distribution network reconfiguration: Past progress and future directions

Revealing the lives of planet-forming disks

What’s really in our food? A global look at food composition databases and the gaps we need to fix

Racial differences in tumor collagen structure may impact cancer prognosis

Museomics highlights the importance of scientific museum collections

Fossil corals point to possibly steeper sea level rise under a warming world

The quantum mechanics of chiral spin selectivity

Bodybuilding in ancient times: How the sea anemone got its back

Science and innovation for a sustainable future

Strange radio pulses detected coming from ice in Antarctica

Amazon trees under pressure: New study reveals how forest giants handle light and heat

Cell-depleting treatment in severe RMD: New data

Vasodilation in systemic sclerosis

New ideas in gout management

Risk factors for progression in spondyloarthritis

Patient experiences In JIA

Patient organizations: The partner by your side

Nurses: A critical role for people with RMD

Online information for patients needs guidance

The many ways that AI enters rheumatology

Pregnancy outcomes in autoinflammatory disease

The value of physical activity for people with RMD

First data from the EULAR RheumaFacts project

[Press-News.org] ASU researchers develop new device to help image key proteins at room temperature